(Q42961436)
Statements
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer (English)
H Wildiers
C Fontaine
P Vuylsteke
M Martens
J L Canon
W Wynendaele
C Focan
P Squifflet